Germ Cell Neoplasm - Miscellaneous

NCT00053352

Trial Number: NCT00053352 (ClinicalTrials.gov)

Disease Type:

Germ Cell Neoplasm - Extragonadal Germ Cell Cancer (excluding Gestational Trophoblastic Disease and Germ Cell Tumors of the CNS)
Germ Cell Neoplasm - Miscellaneous
Germ Cell Neoplasm - Ovarian Germ Cell Cancer
Germ Cell Neoplasm - Testicular Germ Cell Cancer

Trial Title:

A Phase III Study Of Reduced Therapy In The Treatment Of Children With Low And Intermediate Risk Extracranial Germ Cell Tumors

Study ID:

AGCT0132

Images are available?:

Is this a NCI-MATCH Trial?:

Title	Description
NCT00053352-D5	NCT00053352-D5 The dataset provides the information for baseline characteristics and event-free and overall survival for all eligible patients as well as by the different subgroups reported in the manuscript. There is one row per patient.
NCT00053352-D4	NCT00053352-D4 Adverse events. The dataset provides the information for the specific toxicities that occurred during induction and consolidation as reported in the manuscript. There are multiple rows per patient depending on whether they had multiple courses or Adverse events submitted.
NCT00053352-D3	NCT00053352-D3 Historical Control. The dataset provides the information for event-free survival for all eligible historical control patients. It contains all the characteristics needed to do the different subgroup analyses reported in the manuscript. There is one row per patient.
NCT00053352-D2	NCT00053352-D2 The dataset provides the information for baseline characteristics and event-free and overall survival for all eligible patients as well as by the different subgroups reported in the manuscript. There is one row per patient.
NCT00053352-D1	NCT00053352-D1 The dataset provides the information for the consort diagram (Figure 1). There is one row per patient.

Trial Number: NCT00716976 (ClinicalTrials.gov)

Disease Type:

Trial Title:

A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children

Study ID:

ACCL0431

Images are available?:

Is this a NCI-MATCH Trial?:

Title	Description
NCT00716976-D3	NCT00716976-D3 One row for each of the 194 serious adverse events detailed on manuscript page 69. These events are reported through the National Cancer Institute, Cancer Therapy Evaluation Program, Adverse Event Reporting System (CTEP-AERS).
NCT00716976-D2	NCT00716976-D2 These data provide the incidence of toxicities. There is one record per patient-cycle. analysiset2=1 for rows included in Table 3 construction. analysiset3=1 for rows included in Table 4 construction.
NCT00716976-D1	NCT00716976-D1 There is one row for each patient enrolled. The first 14 variables are used to make Figure 1. Patients considered for analysis of study outcomes have the variable analysiset1=1. Variables 15-50 provide patient characteristics (Table 1), outcome (Figures 2 and 3) and hearing loss comparisons (Table 2).

NIH…Turning Discovery Into Health^®